Alternative cleavage and polyadenylation: The long and short of it

Trends in Biochemical Sciences

Volumn 38, Issue 6, 2013, Pages 312-320

  Tian, Bin ^a   Manley, James L ^b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; ISOPROTEIN; MESSENGER RNA; PROTEOME; RNA BINDING PROTEIN; RNA ISOFORM; SMALL NUCLEAR RIBONUCLEOPROTEIN; TRANSCRIPTOME; UNTRANSLATED RNA;

3' UNTRANSLATED REGION; CANCER CELL; CELL GROWTH; CELL MATURATION; CHROMATIN STRUCTURE; EUKARYOTE; EXTRACELLULAR MATRIX; GENE CONTROL; GENE EXPRESSION; GENETIC REGULATION; GENETIC TRANSCRIPTION; GENOMICS; HISTONE MODIFICATION; HUMAN; HUMAN GENOME; METABOLIC REGULATION; MOLECULAR DYNAMICS; NONHUMAN; POLYADENYLATION; PRIORITY JOURNAL; REVIEW; RNA CLEAVAGE; RNA METABOLISM; RNA SPLICING; RNA TRANSCRIPTION; RNA TRANSLATION; TISSUE SPECIFICITY;

HYDROLYSIS; POLY A; PROTEOME; TRANSCRIPTOME;

EUKARYOTA;

EID: 84878151459     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2013.03.005     Document Type: Review

References (104)

1. Richard P., Manley J.L. Transcription termination by nuclear RNA polymerases. Genes Dev. 2009, 23:1247-1269.
2. Marzluff W.F., et al. Metabolism and regulation of canonical histone mRNAs: life without a poly(A) tail. Nat. Rev. Genet. 2008, 9:843-854.
3. Colgan D.F., Manley J.L. Mechanism and regulation of mRNA polyadenylation. Genes Dev. 1997, 11:2755-2766.
4. Danckwardt S., et al. 3' end mRNA processing: molecular mechanisms and implications for health and disease. EMBO J. 2008, 27:482-498.
5. Derti A., et al. A quantitative atlas of polyadenylation in five mammals. Genome Res. 2012, 22:1173-1183.
6. Hoque M., et al. Analysis of alternative cleavage and polyadenylation by 3' region extraction and deep sequencing. Nat. Methods 2013, 10:133-139.
7. Smibert P., et al. Global patterns of tissue-specific alternative polyadenylation in Drosophila. Cell Rep. 2012, 1:277-289.
8. Jan C.H., et al. Formation, regulation and evolution of Caenorhabditis elegans 3'UTRs. Nature 2011, 469:97-101.
9. Ulitsky I., et al. Extensive alternative polyadenylation during zebrafish development. Genome Res. 2012, 22:2054-2066.
10. Di Giammartino D.C., et al. Mechanisms and consequences of alternative polyadenylation. Mol. Cell 2011, 43:853-866.
11. Proudfoot N.J. Ending the message: poly(A) signals then and now. Genes Dev. 2011, 25:1770-1782.
12. Shi Y. Alternative polyadenylation: new insights from global analyses. RNA 2012, 18:2105-2117.
13. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
14. Fabian M.R., Sonenberg N. The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. Nat. Struct. Mol. Biol. 2012, 19:586-593.
15. Sandberg R., et al. Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer microRNA target sites. Science 2008, 320:1643-1647.
16. Ji Z., et al. Progressive lengthening of 3' untranslated regions of mRNAs by alternative polyadenylation during mouse embryonic development. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:7028-7033.
17. Mayr C., Bartel D.P. Widespread shortening of 3' UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 2009, 138:673-684.
18. Boutet S.C., et al. Alternative polyadenylation mediates microRNA regulation of muscle stem cell function. Cell Stem Cell 2012, 10:327-336.
19. Garneau N.L., et al. The highways and byways of mRNA decay. Nat. Rev. Mol. Cell Biol. 2007, 8:113-126.
20. Kim Y.K., et al. Staufen1 regulates diverse classes of mammalian transcripts. EMBO J. 2007, 26:2670-2681.
21. Graham R.R., et al. Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:6758-6763.
22. An J.J., et al. Distinct role of long 3' UTR BDNF mRNA in spine morphology and synaptic plasticity in hippocampal neurons. Cell 2008, 134:175-187.
23. Andreassi C., et al. An NGF-responsive element targets myo-inositol monophosphatase-1 mRNA to sympathetic neuron axons. Nat. Neurosci. 2010, 13:291-301.
24. Yudin D., et al. Localized regulation of axonal RanGTPase controls retrograde injury signaling in peripheral nerve. Neuron 2008, 59:241-252.
25. Zhang H., et al. Biased alternative polyadenylation in human tissues. Genome Biol. 2005, 6:R100.
26. Wang E.T., et al. Transcriptome-wide regulation of pre-mRNA splicing and mRNA localization by muscleblind proteins. Cell 2012, 150:710-724.
27. Chen L.L., Carmichael G.G. Altered nuclear retention of mRNAs containing inverted repeats in human embryonic stem cells: functional role of a nuclear noncoding RNA. Mol. Cell 2009, 35:467-478.
28. Takagaki Y., et al. The polyadenylation factor CstF-64 regulates alternative processing of IgM heavy chain pre-mRNA during B cell differentiation. Cell 1996, 87:941-952.
29. Davis M.J., et al. Differential use of signal peptides and membrane domains is a common occurrence in the protein output of transcriptional units. PLoS Genet. 2006, 2:e46.
30. Vorlova S., et al. Induction of antagonistic soluble decoy receptor tyrosine kinases by intronic polyA activation. Mol. Cell 2011, 43:927-939.
31. Vasudevan S., et al. Non-stop decay - a new mRNA surveillance pathway. Bioessays 2002, 24:785-788.
32. Yao P., et al. Coding region polyadenylation generates a truncated tRNA synthetase that counters translation repression. Cell 2012, 149:88-100.
33. Wang K.C., Chang H.Y. Molecular mechanisms of long noncoding RNAs. Mol. Cell 2011, 43:904-914.
34. Naganuma T., et al. Alternative 3'-end processing of long noncoding RNA initiates construction of nuclear paraspeckles. EMBO J. 2012, 31:4020-4034.
35. Edwalds-Gilbert G., et al. Alternative poly(A) site selection in complex transcription units: means to an end?. Nucleic Acids Res. 1997, 25:2547-2561.
36. Beaudoing E., Gautheret D. Identification of alternate polyadenylation sites and analysis of their tissue distribution using EST data. Genome Res. 2001, 11:1520-1526.
37. Liu D., et al. Systematic variation in mRNA 3'-processing signals during mouse spermatogenesis. Nucleic Acids Res. 2007, 35:234-246.
38. Flavell S.W., et al. Genome-wide analysis of MEF2 transcriptional program reveals synaptic target genes and neuronal activity-dependent polyadenylation site selection. Neuron 2008, 60:1022-1038.
39. Danckwardt S., et al. p38 MAPK controls prothrombin expression by regulated RNA 3' end processing. Mol. Cell 2011, 41:298-310.
40. Li W., et al. Star-PAP control of BIK expression and apoptosis is regulated by nuclear PIPKIalpha and PKCdelta signaling. Mol. Cell 2012, 45:25-37.
41. Ji Z., Tian B. Reprogramming of 3' untranslated regions of mRNAs by alternative polyadenylation in generation of pluripotent stem cells from different cell types. PLoS ONE 2009, 4:e8419.
42. Shepard P.J., et al. Complex and dynamic landscape of RNA polyadenylation revealed by PAS-Seq. RNA 2011, 17:761-772.
43. Park J.Y., et al. Comparative analysis of mRNA isoform expression in cardiac hypertrophy and development reveals multiple post-transcriptional regulatory modules. PLoS ONE 2011, 6:e22391.
44. Mayr C., Bartel D.P. Widespread shortening of 3'UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 2009, 138:673-684.
45. Singh P., et al. Global changes in processing of mRNA 3' untranslated regions characterize clinically distinct cancer subtypes. Cancer Res. 2009, 69:9422-9430.
46. Morris A.R., et al. Alternative cleavage and polyadenylation during colorectal cancer development. Clin. Cancer Res. 2012, 18:5256-5266.
47. Lembo A., et al. Shortening of 3'UTRs correlates with poor prognosis in breast and lung cancer. PLoS ONE 2012, 7:e31129.
48. Elkon R., et al. E2F mediates enhanced alternative polyadenylation in proliferation. Genome Biol. 2012, 13:R59.
49. Fu Y., et al. Differential genome-wide profiling of tandem 3' UTRs among human breast cancer and normal cells by high-throughput sequencing. Genome Res. 2011, 21:741-747.
50. Tian B., et al. A large-scale analysis of mRNA polyadenylation of human and mouse genes. Nucleic Acids Res. 2005, 33:201-212.
51. Martin G., et al. Genome-wide analysis of pre-mRNA 3' end processing reveals a decisive role of human cleavage factor I in the regulation of 3' UTR length. Cell Rep. 2012, 1:753-763.
52. Yao C., et al. Transcriptome-wide analyses of CstF64-RNA interactions in global regulation of mRNA alternative polyadenylation. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:18773-18778.
53. Jenal M., et al. The poly(A)-binding protein nuclear 1 suppresses alternative cleavage and polyadenylation sites. Cell 2012, 149:538-553.
54. Moreira A., et al. The upstream sequence element of the C2 complement poly(A) signal activates mRNA 3' end formation by two distinct mechanisms. Genes Dev. 1998, 12:2522-2534.
55. Millevoi S., Vagner S. Molecular mechanisms of eukaryotic pre-mRNA 3' end processing regulation. Nucleic Acids Res. 2010, 38:2757-2774.
56. Licatalosi D.D., et al. HITS-CLIP yields genome-wide insights into brain alternative RNA processing. Nature 2008, 456:464-469.
57. Wang E.T., et al. Alternative isoform regulation in human tissue transcriptomes. Nature 2008, 456:470-476.
58. Hilgers V., et al. ELAV mediates 3' UTR extension in the Drosophila nervous system. Genes Dev. 2012, 26:2259-2264.
59. Zhu H., et al. Hu proteins regulate polyadenylation by blocking sites containing U-rich sequences. J. Biol. Chem. 2007, 282:2203-2210.
60. Dai W., et al. RNA-binding protein HuR autoregulates its expression by promoting alternative polyadenylation site usage. Nucleic Acids Res. 2012, 40:787-800.
61. Mansfield K.D., Keene J.D. Neuron-specific ELAV/Hu proteins suppress HuR mRNA during neuronal differentiation by alternative polyadenylation. Nucleic Acids Res. 2012, 40:2734-2746.
62. Simpson G.G., et al. FY is an RNA 3' end-processing factor that interacts with FCA to control the Arabidopsis floral transition. Cell 2003, 113:777-787.
63. Lutz C.S., et al. Interaction between the U1 snRNP-A protein and the 160-kD subunit of cleavage-polyadenylation specificity factor increases polyadenylation efficiency in vitro. Genes Dev. 1996, 10:325-337.
64. Kyburz A., et al. Direct interactions between subunits of CPSF and the U2 snRNP contribute to the coupling of pre-mRNA 3' end processing and splicing. Mol. Cell 2006, 23:195-205.
65. Millevoi S., et al. An interaction between U2AF 65 and CF I(m) links the splicing and 3' end processing machineries. EMBO J. 2006, 25:4854-4864.
66. Niwa M., et al. In vitro polyadenylation is stimulated by the presence of an upstream intron. Genes Dev. 1990, 4:1552-1559.
67. Gunderson S.I., et al. U1 snRNP inhibits pre-mRNA polyadenylation through a direct interaction between U1 70K and poly(A) polymerase. Mol. Cell 1998, 1:255-264.
68. Tian B., et al. Widespread mRNA polyadenylation events in introns indicate dynamic interplay between polyadenylation and splicing. Genome Res. 2007, 17:156-165.
69. Peterson M.L., Perry R.P. The regulated production of mu m and mu s mRNA is dependent on the relative efficiencies of mu s poly(A) site usage and the c mu 4-to-M1 splice. Mol. Cell. Biol. 1989, 9:726-738.
70. Kaida D., et al. U1 snRNP protects pre-mRNAs from premature cleavage and polyadenylation. Nature 2010, 468:664-668.
71. Berg M.G., et al. U1 snRNP determines mRNA length and regulates isoform expression. Cell 2012, 150:53-64.
72. Kornblihtt A.R. Promoter usage and alternative splicing. Curr. Opin. Cell Biol. 2005, 17:262-268.
73. Yonaha M., Proudfoot N.J. Specific transcriptional pausing activates polyadenylation in a coupled in vitro system. Mol. Cell 1999, 3:593-600.
74. Cui Y., Denis C.L. In vivo evidence that defects in the transcriptional elongation factors RPB2, TFIIS, and SPT5 enhance upstream poly(A) site utilization. Mol. Cell. Biol. 2003, 23:7887-7901.
75. Martincic K., et al. Transcription elongation factor ELL2 directs immunoglobulin secretion in plasma cells by stimulating altered RNA processing. Nat. Immunol. 2009, 10:1102-1109.
76. Pinto P.A., et al. RNA polymerase II kinetics in polo polyadenylation signal selection. EMBO J. 2011, 30:2431-2444.
77. Rosonina E., et al. Transcriptional activators control splicing and 3'-end cleavage levels. J. Biol. Chem. 2003, 278:43034-43040.
78. Nagaike T., et al. Transcriptional activators enhance polyadenylation of mRNA precursors. Mol. Cell 2011, 41:409-418.
79. Ji Z., et al. Transcriptional activity regulates alternative cleavage and polyadenylation. Mol. Syst. Biol. 2011, 7:534.
80. Glover-Cutter K., et al. RNA polymerase II pauses and associates with pre-mRNA processing factors at both ends of genes. Nat. Struct. Mol. Biol. 2008, 15:71-78.
81. Venkataraman K., et al. Analysis of a noncanonical poly(A) site reveals a tripartite mechanism for vertebrate poly(A) site recognition. Genes Dev. 2005, 19:1315-1327.
82. Rozenblatt-Rosen O., et al. The tumor suppressor Cdc73 functionally associates with CPSF and CstF 3' mRNA processing factors. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:755-760.
83. Calvo O., Manley J.L. Strange bedfellows: polyadenylation factors at the promoter. Genes Dev. 2003, 17:1321-1327.
84. Huang Y., et al. Mediator complex regulates alternative mRNA processing via the MED23 subunit. Mol. Cell 2012, 45:459-469.
85. Uhlmann T., et al. The VP16 activation domain establishes an active mediator lacking CDK8 in vivo. J. Biol. Chem. 2007, 282:2163-2173.
86. Luco R.F., et al. Epigenetics in alternative pre-mRNA splicing. Cell 2011, 144:16-26.
87. Jiang C., Pugh B.F. Nucleosome positioning and gene regulation: advances through genomics. Nat. Rev. Genet. 2009, 10:161-172.
88. Spies N., et al. Biased chromatin signatures around polyadenylation sites and exons. Mol. Cell 2009, 36:245-254.
89. Hu J., et al. Bioinformatic identification of candidate cis-regulatory elements involved in human mRNA polyadenylation. RNA 2005, 11:1485-1493.
90. Grosso A.R., et al. Dynamic transitions in RNA polymerase II density profiles during transcription termination. Genome Res. 2012, 22:1447-1456.
91. Salmena L., et al. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?. Cell 2011, 146:353-358.
92. Johnson S.A., et al. The export factor Yra1 modulates mRNA 3' end processing. Nat. Struct. Mol. Biol. 2011, 18:1164-1171.
93. Wood A.J., et al. Regulation of alternative polyadenylation by genomic imprinting. Genes Dev. 2008, 22:1141-1146.
94. Sheets M.D., et al. Point mutations in AAUAAA and the poly (A) addition site: effects on the accuracy and efficiency of cleavage and polyadenylation in vitro. Nucleic Acids Res. 1990, 18:5799-5805.
95. Cheng Y., et al. Prediction of mRNA polyadenylation sites by support vector machine. Bioinformatics 2006, 22:2320-2325.
96. Nunes N.M., et al. A functional human poly(A) site requires only a potent DSE and an A-rich upstream sequence. EMBO J. 2010, 29:1523-1536.
97. Ozsolak F., et al. Comprehensive polyadenylation site maps in yeast and human reveal pervasive alternative polyadenylation. Cell 2010, 143:1018-1029.
98. Sherstnev A., et al. Direct sequencing of Arabidopsis thaliana RNA reveals patterns of cleavage and polyadenylation. Nat. Struct. Mol. Biol. 2012, 19:845-852.
99. Mangone M., et al. The landscape of C. elegans 3'UTRs. Science 2010, 329:432-435.
100. Haenni S., et al. Analysis of C. elegans intestinal gene expression and polyadenylation by fluorescence-activated nuclei sorting and 3'-end-seq. Nucleic Acids Res. 2012, 40:6304-6318.
101. Wu X., et al. Genome-wide landscape of polyadenylation in Arabidopsis provides evidence for extensive alternative polyadenylation. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:12533-12538.
102. Wilkening S., et al. An efficient method for genome-wide polyadenylation site mapping and RNA quantification. Nucleic Acids Res. 2013, 41:e65.
103. Shi Y., et al. Molecular architecture of the human pre-mRNA 3' processing complex. Mol. Cell 2009, 33:365-376.
104. Mandel C.R., et al. Protein factors in pre-mRNA 3'-end processing. Cell. Mol. Life Sci. 2008, 65:1099-1122.